Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
91 hedge funds and large institutions have $72.6M invested in Tetraphase Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 24 reducing their positions, and 14 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 24
16% more call options, than puts
Call options by funds: $164K | Put options by funds: $141K
1% more funds holding
Funds holding: 90 → 91 (+1)
7% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 14
5% less capital invested
Capital invested by funds: $76.6M → $72.6M (-$4.02M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$763K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$558K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$505K |
| 4 |
Morgan Stanley
New York
|
+$388K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$269K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.54M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$2.52M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.73M |
| 4 |
Renaissance Technologies
New York
|
-$1.48M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.29M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
AQR Capital Management
Greenwich,
Connecticut
| – | -$40K | -517 | Closed |
|
|
AG
102
Advisor Group
Phoenix,
Arizona
| – | -$5K | -67 | Closed |
|
103
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$1.19K | -15 | -60% |
|
|
CG
104
Cutler Group
San Francisco,
California
| – | -$1.03K | -13 | -72% |
|
|
TCM
105
Tradewinds Capital Management
Bellingham,
Washington
| – | -$1K | -13 | Closed |
|
TTPH Hedge Fund Activity: Q4 2016 in Review
91 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q4 2016, worth a combined $72.6M — down 5.3% from $76.6M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new TTPH positions and 14 closed out — a net gain of 1 holder — while 34 added to existing stakes and 24 trimmed.
The largest buyer was Dimensional Fund Advisors, adding an estimated $763K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.54M sold.
- 91 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q4 2016, up from 90 in Q3 2016.
- Funds reported $72.6M of Tetraphase Pharmaceuticals, Inc. stock for Q4 2016, down 5.3% quarter-over-quarter.
- 15 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q4 2016 and 14 closed out, a net change of +1 holder.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q4 2016 was Dimensional Fund Advisors, an estimated $763K added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q4 2016 was Armistice Capital, an estimated $2.54M sold.
Based on aggregated 13F filings for Q4 2016.